Amar Gajjar, M.D.

Oncology, Pediatric Medicine St. Jude Children's Research Hospital, San Francisco, CA, United States 
medulloblastomas, PNET and Rhabdoid tumors (ATRT)
"Amar Gajjar"
Cross-listing: Neuropathology Tree

BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Bagchi A, Orr BA, Campagne O, et al. (2021) Lorlatinib in a Child with -Fusion-Positive High-Grade Glioma. The New England Journal of Medicine. 385: 761-763
Su JM, Kilburn LB, Mansur DB, et al. (2021) Phase 1/2 Trial of Vorinostat and Radiation and Maintenance Vorinostat in Children with Diffuse Intrinsic Pontine Glioma: A Children's Oncology Group Report. Neuro-Oncology
Leary SES, Packer RJ, Li Y, et al. (2021) Efficacy of Carboplatin and Isotretinoin in Children With High-risk Medulloblastoma: A Randomized Clinical Trial From the Children's Oncology Group. Jama Oncology
He C, Xu K, Zhu X, et al. (2021) Patient-derived models recapitulate heterogeneity of molecular signatures and drug response in pediatric high-grade glioma. Nature Communications. 12: 4089
Graham RT, Abu-Arja MH, Stanek JR, et al. (2021) Multi-institutional analysis of treatment modalities in basal ganglia and thalamic germinoma. Pediatric Blood & Cancer. e29172
Michalski JM, Janss AJ, Vezina LG, et al. (2021) Children's Oncology Group Phase III Trial of Reduced-Dose and Reduced-Volume Radiotherapy With Chemotherapy for Newly Diagnosed Average-Risk Medulloblastoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2002730
Ali JS, Ashford JM, Swain MA, et al. (2021) Predictors of Cognitive Performance Among Infants Treated for Brain Tumors: Findings From a Multisite, Prospective, Longitudinal Trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2001687
Levy AS, Krailo M, Chi S, et al. (2021) Temozolomide with irinotecan versus temozolomide, irinotecan plus bevacizumab for recurrent medulloblastoma of childhood: Report of a COG randomized Phase II screening trial. Pediatric Blood & Cancer. e29031
Khan RB, Patay Z, Klimo P, et al. (2021) Clinical features, neurologic recovery, and risk factors of post-operative posterior fossa syndrome and delayed recovery: A prospective study. Neuro-Oncology
Partanen M, Anghelescu DL, Hall L, et al. (2021) Longitudinal associations between exposure to anesthesia and neurocognitive functioning in pediatric medulloblastoma. European Journal of Cancer (Oxford, England : 1990). 148: 103-111
See more...